+1-888-308-5802     
News Contact Us

UK-Texas collaboration to offer new growth prospects in life sciences

Author : Pankaj Singh | Published Date : 2018-09-14 

The Texas Medical Center (TMC), which is home to the US’ leading cancer hospital and a total of 61 world leading innovators, will now offer a unique package to UK companies that will help boost innovations in life sciences and drive exports. Supposedly, the partnership will enable research collaboration on various medical issues, including the development and advancement of cancer treatments and genomics.

British life sciences firms will allegedly have the chance to shift to the TMC in Houston, gaining access to its medical experts, advisors and investors. This partnership is a significant forward leap for the TMC’s research program as it looks to utilize UK’s world-renowned research and development capabilities, sources familiar with the matter mentioned.

Baroness Fairhead, UK’s Minister of State for the Department for International Trade, stated in an event that the UK is a world leader in healthcare innovation, and this collaboration is a confirmation of the opportunities in markets like the U.S. that exist for British companies. He added that their recent Export Strategy will assist other British life sciences companies to reach new markets and boost the availability of innovative healthcare services globally.

William McKeon, President & CEO of TMC said in a statement that this unique partnership is an evidence of the Texas Medical Center’s and the United Kingdom’s joint commitment towards promoting the exchange of ideas, innovation, and people in the life sciences. He believes this new relationship will assist in forming a strategic alliance between TMC and a country that has been leading medical innovation for centuries.

The current chief executive of UK Research and Innovation and a former government chief scientist, Sir Mark Walport commented on the partnership saying it will prove to be a valuable asset for UK and US healthcare professionals who are putting in great efforts in the development of medical treatments for people around the world.

Apparently, healthcare trusts in Manchester, Cambridge and Leeds are in talks with institutions at TMC and will attempt to formalize valuable partnerships soon.

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Cipla launches generic version of Remdesivir at a price of ₹4,000

Published Date: 2020-07-10         Author: Pankaj Singh

Cipla Limited, the multinational pharmaceutical company, has reportedly launched a generic version of the remdesivir drug (Cipremi) at a price of ?4,000 per 100 mg vial, making it among the least priced COVID-19 treatment available across the globe. According to sources familiar with the knowledg... Read More

Revival in UK hotel bookings after COVID-19 downturn, says Premier Inn

Published Date: 2020-07-09         Author: Pankaj Singh

UK has registered a revival in hotel bookings for conventional regional tourist destinations as people have started planning summer trips to the seaside and countryside, stated Premier Inn owner. The Chief Executive of Whitbread, Alison Brittain, has stated that larger cities like London continue... Read More

Fujitsu gravitates toward 'new normal' with new office working style

Published Date: 2020-07-08         Author: Pankaj Singh

Fujitsu Limited, a Japanese multinational IT company headquartered in Tokyo, has reportedly announced that it will boost its shift to becoming a digital transformation organization with an ambitious plan to transform the working style for its employees in Japan in the light of COVID-19 pandemic. ... Read More

© 2020 Fractovia. All Rights Reserved